What earlier endocrine care records actually show
Earlier endocrine care is not a single document. It is a sequence of hormone measurements, visual-field tests, imaging and clinical notes that together describe how a pituitary adenoma has behaved over time. A single prolactin value from six months ago tells a different story than a trend of prolactin values alongside a visual-field test showing a new defect. The receiving clinician needs the sequence, not just the latest number.
Hormone results matter because pituitary adenomas can be functioning or non-functioning. A functioning tumour may overproduce prolactin, growth hormone, ACTH or another hormone, and that changes whether medical therapy, surgery or another approach is considered. A non-functioning tumour may be followed with imaging and visual-field monitoring. The same imaging finding can lead to different decisions depending on the hormone pattern.
Visual-field results matter because the pituitary sits close to the optic chiasm. A visual-field test that shows a bitemporal defect suggests the tumour is pressing on the visual pathway. That finding can shift the urgency of assessment. A normal visual field does not rule out a problem, but it is part of the picture the treating team uses.
The practical point is that earlier endocrine care records are evidence of a trajectory. When you present them in China, the clinician is looking for direction of change, response to any prior treatment, and whether the current symptoms match the recorded findings. If the records are incomplete, the clinician may need to repeat tests or ask for specific missing items. That is a clinical decision, not a paperwork preference.
Why the distinction between confirmed and suspected cases changes the questions
A confirmed pituitary adenoma and a suspected one lead to different conversations. If the diagnosis is already established by imaging and hormone testing, the China review is about management: whether surgery is appropriate, whether medical therapy is an option, and what monitoring is needed. If the diagnosis is still being clarified, the review is about what tests are needed to confirm it and what the differential includes.
For a confirmed case, the key questions are about the specific tumour type and its behaviour. Is it functioning or non-functioning? If functioning, which hormone is elevated and by how much? Has there been any visual-field change? Has any medical treatment already been tried, and what was the response? These answers determine whether endoscopic transsphenoidal surgery, medical management or watchful waiting is discussed.
For a suspected case, the questions are different. What imaging has been done, and what did it show? Which hormone tests have been run, and were they done under the right conditions? Are there symptoms such as headaches, visual changes, or features of hormone excess or deficiency? The receiving clinician may need to order additional tests before any treatment decision.
This distinction matters for how you write your enquiry. If you send a summary that says "pituitary adenoma" without specifying whether it is confirmed and what the hormone and visual-field results show, the coordinator cannot route your case appropriately. A short, structured summary with the actual findings is more useful than a long narrative.
Surgery and medical alternatives: what the records need to support
Endoscopic transsphenoidal pituitary surgery accesses the pituitary region through the nose. It is one option for some pituitary adenomas, but it is not the only option and not every pituitary adenoma needs surgery. The decision depends on the tumour type, size, hormone activity, visual-field findings, symptoms and the patient's overall health.
Medical alternatives also depend on the records. For prolactin-secreting adenomas, dopamine agonist therapy is a recognised approach in many cases. For other functioning tumours, different medications may be considered. For non-functioning tumours without visual compromise, monitoring may be appropriate. These are clinical judgements that require the actual hormone values and imaging, not a general description.
When you present earlier endocrine care records, the receiving clinician is looking for whether a medical trial has already been attempted and what happened. If prolactin was elevated and a dopamine agonist was tried, the response or lack of response is directly relevant to whether surgery is discussed. If no medical trial has been attempted, that may be part of the conversation. The records need to show the treatment history, not just the diagnosis.
The source material for this article notes that hormone and vision issues can be relevant to assessment. It does not provide hormone-replacement instructions, fluid restrictions, steroid changes or visual-recovery promises. Those are decisions for the treating clinician after reviewing the individual case. If you have questions about medication changes or steroid management, those must be directed to the treating team, not inferred from a general article.
How to present earlier endocrine care without rewriting a first-visit guide
The goal is not to produce a complete medical archive. It is to give the receiving clinician a clear, accurate picture of what has already been done and what the results show. A structured summary with the key findings is more useful than a chronological account of every appointment.
Start with the confirmed diagnosis or the current working diagnosis. State whether the adenoma is confirmed by imaging and, if known, whether it is functioning or non-functioning. If the hormone type is known, name it. If it is not known, say that.
Then list the hormone results with dates and units. Include the specific hormone, the value, the reference range if available, and the date. If there is a trend, show the trend. For example, a series of prolactin values over time is more informative than a single number. If growth hormone or IGF-1 has been measured, include those. If ACTH or cortisol has been assessed, include the results and any dynamic testing.
Next, include the visual-field results with dates. State whether the test was normal or showed a defect, and describe the defect if one was found. If visual acuity was tested, include that as well. If no visual-field testing has been done, say so, because that may be a gap the receiving clinician wants to address.
Finally, include the imaging. State the modality, the date, and the key findings: tumour size, location, and whether there is any compression of the optic chiasm or cavernous sinus. If there are prior imaging studies, note whether comparison shows growth, stability or change.
This structure lets the receiving clinician see the trajectory at a glance. It also makes clear what is missing, so the China team can tell you what additional information or testing may be needed before a treatment decision.
- Confirmed diagnosis and whether the adenoma is functioning or non-functioning
- Hormone results with dates, units and reference ranges, including any trend
- Visual-field and visual-acuity results with dates
- Imaging modality, date and key findings including size and compression
- Any prior medical treatment and the response
What to ask the China team before you travel
Before committing to travel, you need to know whether the China team can actually assess your case with the records you have, and what they would need to decide on a management plan. The answers to these questions determine whether a remote review is useful or whether you need to be seen in person first.
Ask whether the hospital can review your earlier endocrine care records remotely and give a records-based opinion. Ask what specific records they need that you have not already provided. Ask whether they would want repeat hormone testing or visual-field testing in China, and whether that can be arranged before a treatment decision.
Ask how the team would approach the surgery versus medical alternatives question in your case. You are not asking for a guarantee or a recommendation before they have seen the records. You are asking what information they need to have that discussion. If the answer is vague, that is useful information about whether the hospital is the right fit.
Ask about the practical arrangements: how to share records securely, what language support is available, and how the appointment and admission process works if surgery is recommended. These are coordination questions, not clinical ones, and they can be answered before you commit to travel.
Do not delay necessary local care while pursuing an overseas enquiry. If you have worsening vision, severe headaches or symptoms of hormone crisis, seek local medical assessment first. An overseas review can proceed in parallel, but it does not replace urgent local care.
Next step: a short summary, not a full archive
The first step is a brief summary through the enquiry form, email or WhatsApp. Include your diagnosis status, the key hormone and visual-field findings with dates, and your main question. You do not need to send a complete medical archive at this stage, and you should not send passport numbers or payment details.
The initial case review is free and non-clinical. It checks whether the available records and your question can be matched to a relevant next step. It is not a diagnosis, a treatment recommendation or a promise of hospital acceptance. If a records-based specialist opinion is useful, that can be discussed separately, but it is not a prerequisite for every appointment.
The hospital decides suitability and acceptance. No outcome is guaranteed. The treating clinician will confirm what testing, treatment or monitoring is appropriate after reviewing your individual case.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.